English

PONIARD PHARMACEUTICALS, INC.

EDGAR

Quarterly report (10-Q) · filed 2011-10-28

74 filing records in this dataset, filed from 1995-05-11 to 2011-10-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-11.1 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -11052000 USD Source

Cash and cash equivalents: 1.98 million Unit12 2011-09-30 Source
Exact value

1984000 Unit12
Long-term debt including current maturities: Not available
Shares outstanding: 59.9 million Unit1 2011-09-30 Source
Exact value

59944271 Unit1

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 0 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 0 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 0 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 0 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 0 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-10-28.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2008-12-31
Operating income: 11 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2010-12-31
capital expenditure: No compatible figures in this window
Total assets: 1 of 11 periods available· newest 2010-12-31
liabilities: No compatible figures in this window
Current assets: 1 of 11 periods available· newest 2010-12-31
Current liabilities: 1 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
Shares outstanding: 1 of 11 periods available· newest 2010-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 15.66 million

Prior period

−USD 45.72 million

2009-01-01 – 2009-12-31
Current period

−USD 30.05 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-30051000 − -45715000 = 15664000 USD

-45715000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-30051000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PONIARD PHARMACEUTICALS, INC. · 2010-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Year-over-year change in Net income: 15664000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -30051000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#5882 Input fundies:NetIncome: -45715000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#5882
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 11.22 million

Prior period

−USD 35.49 million

2009-01-01 – 2009-12-31
Current period

−USD 24.28 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-24276000 − -35491000 = 11215000 USD

-35491000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-24276000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PONIARD PHARMACEUTICALS, INC. · 2010-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Year-over-year change in Operating cash flow: 11215000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -24276000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#6062 Input fundies:OperatingCashFlow: -35491000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#6062
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 0
Operating costs Derived USD 49.16 million
Operating income −USD 49.16 million
Tax, interest and other Derived −USD 592,000
Net income −USD 48.57 million

Cash

Operating cash flow −USD 33.49 million
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 1,010% of revenue.
2002 Operating loss: operating costs were 316% of revenue.
2003 Operating loss: operating costs were 145% of revenue.
2004 Operating loss: operating costs were 2,020% of revenue.
2005 Operating loss: operating costs were 140,500% of revenue.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	2873000	29020000 Derived	-26147000	-2345000 Derived	-23802000	Unavailable	Source 2001-01-01 – 2001-12-31: 2873000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -26147000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -23802000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -18511000 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	11054000	34949000 Derived	-23895000	-802000 Derived	-23093000	Unavailable	Source 2002-01-01 – 2002-12-31: 11054000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -23895000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -23093000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -15409000 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	10531000	15218000 Derived	-4687000	372000 Derived	-5059000	Unavailable	Source 2003-01-01 – 2003-12-31: 10531000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -4687000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -5059000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -4066000 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	1015000	20502000 Derived	-19487000	-116000 Derived	-19371000	Unavailable	Source 2004-01-01 – 2004-12-31: 1015000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -19487000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -19371000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -17480000 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	15000	21075000 Derived	-21060000	-63000 Derived	-20997000	Unavailable	Source 2005-01-01 – 2005-12-31: 15000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -21060000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -20997000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -16467000 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	0	21234000 Derived	-21234000	2060000 Derived	-23294000	Unavailable	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -21234000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -23294000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -17274000 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	0	35353000 Derived	-35353000	-2571000 Derived	-32782000	Unavailable	Source 2007-01-01 – 2007-12-31: 0 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -35353000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -32782000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -24653000 USD Inspect Operating Cash Flow Open source
2008 2008-01-01 – 2008-12-31	0	49157000 Derived	-49157000	-592000 Derived	-48565000	Unavailable	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -49157000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -48565000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -33487000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	3549000	Revenue: 3549000 Open source
20012001-12-31	Revenue	2873000	Revenue: 2873000 Open source
20022002-12-31	Revenue	11054000	Revenue: 11054000 Open source
20032003-12-31	Revenue	10531000	Revenue: 10531000 Open source
20042004-12-31	Revenue	1015000	Revenue: 1015000 Open source
20052005-12-31	Revenue	15000	Revenue: 15000 Open source
20062006-12-31	Revenue	0	Revenue: 0 Open source
20072007-12-31	Revenue	0	Revenue: 0 Open source
20082008-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 3549000 Open source
20012001-12-31	Year over year	-19%	Revenue: 2873000 Open source Revenue: 3549000 Open source
20022002-12-31	Year over year	284.8%	Revenue: 11054000 Open source Revenue: 2873000 Open source
20032003-12-31	Year over year	-4.7%	Revenue: 10531000 Open source Revenue: 11054000 Open source
20042004-12-31	Year over year	-90.4%	Revenue: 1015000 Open source Revenue: 10531000 Open source
20052005-12-31	Year over year	-98.5%	Revenue: 15000 Open source Revenue: 1015000 Open source
20062006-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 15000 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -140,400% 2005

Net margin -139,980% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	-508.5%	Operating Income: -18045000 Open source Revenue: 3549000 Open source
20012001-12-31	Operating margin	-910.1%	Operating Income: -26147000 Open source Revenue: 2873000 Open source
20022002-12-31	Operating margin	-216.2%	Operating Income: -23895000 Open source Revenue: 11054000 Open source
20032003-12-31	Operating margin	-44.5%	Operating Income: -4687000 Open source Revenue: 10531000 Open source
20042004-12-31	Operating margin	-1,919.9%	Operating Income: -19487000 Open source Revenue: 1015000 Open source
20052005-12-31	Operating margin	-140,400%	Operating Income: -21060000 Open source Revenue: 15000 Open source
20062006-12-31	Operating margin	Not reported	Operating Income: -21234000 Open source Revenue: 0 Open source
20072007-12-31	Operating margin	Not reported	Operating Income: -35353000 Open source Revenue: 0 Open source
20082008-12-31	Operating margin	Not reported	Operating Income: -49157000 Open source Revenue: 0 Open source
20002000-12-31	Net margin	-321.3%	Net Income: -11402000 Open source Revenue: 3549000 Open source
20012001-12-31	Net margin	-828.5%	Net Income: -23802000 Open source Revenue: 2873000 Open source
20022002-12-31	Net margin	-208.9%	Net Income: -23093000 Open source Revenue: 11054000 Open source
20032003-12-31	Net margin	-48%	Net Income: -5059000 Open source Revenue: 10531000 Open source
20042004-12-31	Net margin	-1,908.5%	Net Income: -19371000 Open source Revenue: 1015000 Open source
20052005-12-31	Net margin	-139,980%	Net Income: -20997000 Open source Revenue: 15000 Open source
20062006-12-31	Net margin	Not reported	Net Income: -23294000 Open source Revenue: 0 Open source
20072007-12-31	Net margin	Not reported	Net Income: -32782000 Open source Revenue: 0 Open source
20082008-12-31	Net margin	Not reported	Net Income: -48565000 Open source Revenue: 0 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 3549000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 2873000 Open source Operating Cash Flow: -18511000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 11054000 Open source Operating Cash Flow: -15409000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 10531000 Open source Operating Cash Flow: -4066000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 1015000 Open source Operating Cash Flow: -17480000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 15000 Open source Operating Cash Flow: -16467000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -17274000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -24653000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -33487000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -33.5M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	Not reported	No source recorded
20012001-12-31	Operating cash flow	-18511000	Operating Cash Flow: -18511000 Open source
20022002-12-31	Operating cash flow	-15409000	Operating Cash Flow: -15409000 Open source
20032003-12-31	Operating cash flow	-4066000	Operating Cash Flow: -4066000 Open source
20042004-12-31	Operating cash flow	-17480000	Operating Cash Flow: -17480000 Open source
20052005-12-31	Operating cash flow	-16467000	Operating Cash Flow: -16467000 Open source
20062006-12-31	Operating cash flow	-17274000	Operating Cash Flow: -17274000 Open source
20072007-12-31	Operating cash flow	-24653000	Operating Cash Flow: -24653000 Open source
20082008-12-31	Operating cash flow	-33487000	Operating Cash Flow: -33487000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	Unavailable	No source recorded
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -18511000 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -15409000 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4066000 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -17480000 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -16467000 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -17274000 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -24653000 Open source
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -33487000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Liabilities / assets	Not reported	No source recorded
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	No source recorded
2004-12-31	Liabilities / assets	Not reported	No source recorded
2005-12-31	Liabilities / assets	Not reported	No source recorded
2006-12-31	Liabilities / assets	Not reported	No source recorded
2007-12-31	Liabilities / assets	Not reported	No source recorded
2008-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Current assets / current liabilities	Not reported	No source recorded
2001-12-31	Current assets / current liabilities	Not reported	No source recorded
2002-12-31	Current assets / current liabilities	Not reported	No source recorded
2003-12-31	Current assets / current liabilities	Not reported	No source recorded
2004-12-31	Current assets / current liabilities	Not reported	No source recorded
2005-12-31	Current assets / current liabilities	Not reported	No source recorded
2006-12-31	Current assets / current liabilities	Not reported	No source recorded
2007-12-31	Current assets / current liabilities	Not reported	No source recorded
2008-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 23.8 million Exact value Exact value: -23802000 USD 2001-01-01 – 2001-12-31: -23802000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2001-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -23802000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23802000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-04-007097.txt#5219 The citation records this snapshot. The page link may show a newer release later.	−USD 18.51 million Exact value Exact value: -18511000 USD 2001-01-01 – 2001-12-31: -18511000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2001-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -18511000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18511000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-04-007097.txt#5484 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 23.09 million Exact value Exact value: -23093000 USD 2002-01-01 – 2002-12-31: -23093000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2002-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -23093000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23093000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001104659-05-013431.txt#11017 The citation records this snapshot. The page link may show a newer release later.	−USD 15.41 million Exact value Exact value: -15409000 USD 2002-01-01 – 2002-12-31: -15409000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2002-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -15409000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15409000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001104659-05-013431.txt#11469 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 5.06 million Exact value Exact value: -5059000 USD 2003-01-01 – 2003-12-31: -5059000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2003-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -5059000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5059000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001104659-06-013121.txt#10612 The citation records this snapshot. The page link may show a newer release later.	−USD 4.07 million Exact value Exact value: -4066000 USD 2003-01-01 – 2003-12-31: -4066000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2003-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -4066000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4066000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001104659-06-013121.txt#11041 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 19.37 million Exact value Exact value: -19371000 USD 2004-01-01 – 2004-12-31: -19371000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2004-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -19371000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19371000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001104659-07-019834.txt#7079 The citation records this snapshot. The page link may show a newer release later.	−USD 17.48 million Exact value Exact value: -17480000 USD 2004-01-01 – 2004-12-31: -17480000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2004-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -17480000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17480000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001104659-07-019834.txt#7462 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 21 million Exact value Exact value: -20997000 USD 2005-01-01 – 2005-12-31: -20997000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2005-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -20997000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20997000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-08-002711.txt#4280 The citation records this snapshot. The page link may show a newer release later.	−USD 16.47 million Exact value Exact value: -16467000 USD 2005-01-01 – 2005-12-31: -16467000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2005-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -16467000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16467000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-08-002711.txt#4492 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 23.29 million Exact value Exact value: -23294000 USD 2006-01-01 – 2006-12-31: -23294000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2006-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -23294000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23294000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-09-002743.txt#5904 The citation records this snapshot. The page link may show a newer release later.	−USD 17.27 million Exact value Exact value: -17274000 USD 2006-01-01 – 2006-12-31: -17274000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2006-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -17274000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17274000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-09-002743.txt#6099 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 32.78 million Exact value Exact value: -32782000 USD 2007-01-01 – 2007-12-31: -32782000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2007-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -32782000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32782000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-10-002295.txt#7848 The citation records this snapshot. The page link may show a newer release later.	−USD 24.65 million Exact value Exact value: -24653000 USD 2007-01-01 – 2007-12-31: -24653000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2007-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -24653000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24653000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-10-002295.txt#8056 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 48.57 million Exact value Exact value: -48565000 USD 2008-01-01 – 2008-12-31: -48565000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2008-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -48565000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48565000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-10-002295.txt#7848 The citation records this snapshot. The page link may show a newer release later.	−USD 33.49 million Exact value Exact value: -33487000 USD 2008-01-01 – 2008-12-31: -33487000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2008-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -33487000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33487000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001047469-10-002295.txt#8056 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 45.72 million Exact value Exact value: -45715000 USD 2009-01-01 – 2009-12-31: -45715000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2009-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -45715000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45715000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#5882 The citation records this snapshot. The page link may show a newer release later.	−USD 35.49 million Exact value Exact value: -35491000 USD 2009-01-01 – 2009-12-31: -35491000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2009-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -35491000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35491000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#6062 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 30.05 million Exact value Exact value: -30051000 USD 2010-01-01 – 2010-12-31: -30051000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PONIARD PHARMACEUTICALS, INC. · 2010-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Net Income: -30051000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30051000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#5882 The citation records this snapshot. The page link may show a newer release later.	−USD 24.28 million Exact value Exact value: -24276000 USD 2010-01-01 – 2010-12-31: -24276000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PONIARD PHARMACEUTICALS, INC. · 2010-12-31 PONIARD PHARMACEUTICALS, INC. (edgar:755806) Operating Cash Flow: -24276000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/755806/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24276000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/755806/0001193125-11-082965.txt#6062 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

74 filings · 169 latest values · 169 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000755806, 755806, edgar:755806

Also known as NEORX CORP, PONIARD PHARMACEUTICALS, INC.

PONIARD PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Revenue

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation